The Bloomberg and Alphabet-backed CRM platform developer has boosted its series C round to $68m with a $15m extension.

Seek is set to exit employee scheduling software provider Ximble in an acquisition by Paycor, three years after investing $4m in the company.

University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.

The Orange-backed electronics financing provider has increased its total equity and debt financing to $70m with a Greylock-led series B round.

Jaguar Land Rover has exited mobility rewards app developer Validated in an acquisition of undisclosed size by Moovel.

Merck & Co and Lilly Asia Ventures will exit the biotherapeutics technology developer in an acquisition by Evotec that will be sized at up to $90m.

Eli Lilly, WuXi Biologics and Alexandria-backed cancer and orphan disease therapy developer Inhibrx has received $40m in funding from Viking Global Investors.

The 3D-imaging interior design service took its overall funding to more than $70m in a round that featured Comcast Ventures and Advance Venture Partners.

MassMutual Ventures co-led the healthcare data platform developer's series B round, which also featured Aviva Ventures and Jianke.

ServiceNow has named Claire Lecarpentier, formerly a strategic investor at JP Morgan, as corporate strategy manager for its ServiceNow Ventures subsidiary.